The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation
Abstract
Objectives.: To perform a systematic investigation of medications associated with adverse sedation events in pediatric patients using critical incident analysis of case reports. Methods.: One hundred eighteen case reports from the adverse drug reporting system of the Food and Drug Administration, the US Pharmacopoeia, and the results of a survey of pediatric specialists were used. Outcome measures were death, permanent neurologic injury, prolonged hospitalization without injury, and no harm. The overall results of the critical incident analysis are reported elsewhere. The current investigation specifically examined the relationship between outcome and medications: individual and classes of drugs, routes of administration, drug combinations and interactions, medication errors and overdoses, patterns of drug use, practitioners, and venues of sedation. Results.: Ninety-five incidents fulfilled study criteria and all 4 reviewers agreed on causation; 60 resulted in death or permanent neurologic injury. Review of adverse sedation events indicated that there was no relationship between outcome and drug class (opioids; benzodiazepines; barbiturates; sedatives; antihistamines; and local, intravenous, or inhalation anesthetics) or route of administration (oral, rectal, nasal, intramuscular, intravenous, local infiltration, and inhalation). Negative outcomes (death and permanent neurologic injury) were often associated with drug overdose (n = 28). Some drug overdoses were attributable to prescription/transcription errors, although none of 39 overdoses in 34 patients seemed to be a decimal point error. Negative outcomes were also associated with drug combinations and interactions. The use of 3 or more sedating medications compared with 1 or 2 medications was strongly associated with adverse outcomes (18/20 vs 7/70). Nitrous oxide in combination with any other class of sedating medication was frequently associated with adverse outcomes (9/10). Dental specialists had the greatest frequency of negative outcomes associated with the use of 3 or more sedating medications. Adverse events occurred despite drugs being administered within acceptable dosing limits. Negative outcomes were also associated with drugs administered by nonmedically trained personnel and drugs administered at home. Some injuries occurred on the way to a facility after administration of sedatives at home; some took place in automobiles or at home after discharge from medical supervision. Deaths and injuries after discharge from medical supervision were associated with the use of medications with long half-lives (chloral hydrate, pentobarbital, promazine, promethazine, and chlorpromazine). Conclusions.: Adverse sedation events were frequently associated with drug overdoses and drug interactions, particularly when 3 or more drugs were used. Adverse outcome was associated with all routes of drug administration and all classes of medication, even those (such as chloral hydrate) thought to have minimal effect on respiration. Patients receiving medications with long plasma half-lives may benefit from a prolonged period of postsedation observation. Adverse events occurred when sedative medications were administered outside the safety net of medical supervision. Uniform monitoring and training standards should be instituted regardless of the subspecialty or venue of practice. Standards of care, scope of practice, resource management, and reimbursement for sedation should be based on the depth of sedation achieved (ie, the degree of vigilance and resuscitation skills required) rather than on the drug class, route of drug administration, practitioner, or venue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Brennan, T. A., Leape, L. L., Laird, N. M., Hebert, L., Localio, A. R., Lawthers, A. G., Newhouse, J. P., Weiler, P. C., & Hiatt, H. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240604 · Cited by 4,627
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529786 · Cited by 4,332
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Leape, L. L. (1994) · PubMed · Cited by 1,961
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Leape, L. L. (1999) · JAMA · doi:10.1001/jama.282.3.267 · Cited by 1,599
Leape, L. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230061039 · Cited by 1,425
Coté, C. J., Wilson, S., AMERICAN ACADEMY OF PEDIATRICS, & AMERICAN ACADEMY OF PEDIATRIC DENTISTRY (2019) · Pediatrics · doi:10.1542/peds.2019-1000 · Cited by 1,406
Systems Analysis of Adverse Drug Events
Leape, L. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530010049034 · Cited by 1,404
The Impact of Computerized Physician Order Entry on Medication Error Prevention
Bates, D. W., Teich, J. M., Lee, J., Seger, D., Kuperman, G. J., Ma'Luf, N., Boyle, D., & Leape, L. (1999) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1999.00660313 · Cited by 1,260
Relationship between medication errors and adverse drug events
Bates, D. W., Boyle, D. L., Vliet, M. B. V., Schneider, J., & Leape, L. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02600255 · Cited by 981
Silber, J. H., Williams, S. V., Krakauer, H., & Schwartz, S. (1992) · Medical Care · doi:10.1097/00005650-199207000-00004 · Cited by 952
Committee on Drugs (1992) · Pediatrics · doi:10.1542/peds.89.6.1110 · Cited by 745
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., & Wilkinson, G. R. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107938 · Cited by 696
Frequent Hypoxemia and Apnea after Sedation with Midazolam and Fentanyl
Bailey, P. L., Pace, N. L., Ashburn, M. A., Moll, J. W. B., East, K. A., & Stanley, T. H. (1990) · Anesthesiology · doi:10.1097/00000542-199011000-00005 · Cited by 643
The Incident Reporting System Does Not Detect Adverse Drug Events: A Problem for Quality Improvement
Cullen, D. J., Bates, D. W., Small, S. D., Cooper, J. B., Nemeskal, A. R., & Leape, L. L. (1995) · The Joint Commission Journal on Quality Improvement · doi:10.1016/s1070-3241(16)30180-8 · Cited by 600
Adverse Sedation Events in Pediatrics: A Critical Incident Analysis of Contributing Factors
Coté, C. J., Notterman, D. A., Karl, H. W., Weinberg, J. A., & McCloskey, C. (2000) · Pediatrics · doi:10.1542/peds.105.4.805 · Cited by 593
Self-citation(2018) · CRC Press eBooks · doi:10.1201/9780203751725 · Cited by 573
McClain, D. A., & Hug, C. C. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.138 · Cited by 515
Leape, L. L., Lawthers, A. G., Brennan, T. A., & Johnson, W. G. (1993) · QRB - Quality Review Bulletin · doi:10.1016/s0097-5990(16)30608-x · Cited by 429
ASHP Guidelines on Preventing Medication Errors in Hospitals
Billstein-Leber, M., Carrillo, C. J. D., Cassano, A. T., Moline, K., & Robertson, J. J. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170811 · Cited by 398
Medication Prescribing Errors in a Teaching Hospital
Lesar, T. S. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440170051035 · Cited by 396
Costs of medical injuries in Utah and Colorado.
Thomas, E. J., Studdert, D. M., Newhouse, J. P., Zbar, B. I. W., Howard, K., WILLIAMS, E. J., & Brennan, T. A. (1999) · PubMed · Cited by 395
Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives
Mather, L. E. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308050-00004 · Cited by 393
Incidence and preventability of adverse drug events in hospitalized adults
Bates, D. W., Leape, L. L., & Petrycki, S. (1993) · Journal of General Internal Medicine · doi:10.1007/bf02600138 · Cited by 373
A potentially hazardous interaction between erythromycin and midazolam
Olkkola, K. T., Aranko, K., Luurila, H., Hiller, A., Saarnivaara, L., Himberg, J.-J., & Neuvonen, P. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.25 · Cited by 351
Clinical Pharmacokinetics of H1-Receptor Antagonists (The Antihistamines)
Paton, D. M., & Webster, D. R. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510060-00002 · Cited by 334
Silber, J. H. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530040045039 · Cited by 314
Ramifications of a Population Model for κ as a Coefficient of Reliability
Kraemer, H. C. (1979) · Psychometrika · doi:10.1007/bf02296208 · Cited by 293
The pharmacokinetics of midazolam in man
Smith, M. T., Eadie, M. J., & Brophy, T. O. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562804 · Cited by 276
The pharmacokinetics of midazolam in paediatric patients
Payne, K., Mattheyse, F. J., Liebenberg, D., & Dawes, T. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00679782 · Cited by 276
Kinetics of intravenous and intramuscular morphine
Stanski, D. R., Greenblatt, D. J., & Lowenstein, E. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197824152 · Cited by 237
The moral limits of Feinberg's liberalism
Doppelt, G. (1993) · Inquiry · doi:10.1080/00201749308602322 · Cited by 231
Measuring interrater reliability among multiple raters: An example of methods for nominal data
Posner, K. L., Sampson, P. D., Caplan, R. A., Ward, R. J., & Cheney, F. W. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090917 · Cited by 229
Dose of midazolam should be reduced during diltiazem and verapamil treatments.
Backman, J., Olkkola, K., Aranko, K., Himberg, J., & Neuvonen, P. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04266.x · Cited by 184
Greenberg, S. B., Faerber, E. N., Aspinall, C. L., & Adams, R. C. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.161.3.8352124 · Cited by 182
Brennan, T. A., Localio, A. R., Leape, L. L., Laird, N. M., Peterson, L., Hiatt, H. H., & Barnes, B. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-3-221 · Cited by 167
ASHP Guidelines on Preventing Medication Errors in Hospitals
(1993) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/50.2.305 · Cited by 167
Rey, E., Delaunay, L., Pons, G., Murat, I., Richard, M. O., Saint-Maurice, C., & Olive, G. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314967 · Cited by 158
UNCONSCIOUSNESS ASSOCIATED WITH MIDAZOLAM AND ERYTHROMYCIN
Hiller, A., Olkkola, K. T., ISOHANNI, P., et al. (1990) · British Journal of Anaesthesia · doi:10.1093/bja/65.6.826 · Cited by 133
Diphenhydramine: Pharmacokinetics and Pharmacodynamics in Elderly Adults, Young Adults, and Children
Simons, K. J., Watson, W. T. A., Martin, T. J., Chen, M. X. Y., & Simons, F. E. R. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01871.x · Cited by 129
Diazepam Kinetics in Relation to Age and Sex
Ochs, H. R., Greenblatt, D. J., Divoll, M., Abernethy, D. R., Feyerabend, H., & Dengler, H. J. (2008) · Pharmacology · doi:10.1159/000137524 · Cited by 114
Risks to Children From Computed Tomographic Scan Premedication
Mitchell, A. A. (1982) · JAMA · doi:10.1001/jama.1982.03320420035028 · Cited by 111
Using information systems to measure and improve quality
Bates, D. W., Pappius, E. M., Kuperman, G. J., Sittig, D. F., Burstin, H. R., Fairchild, D. G., Brennan, T. A., & Teich, J. M. (1999) · International Journal of Medical Informatics · doi:10.1016/s1386-5056(98)00152-x · Cited by 111
Pharmacokinetics of chlorpromazine after single and chronic dosage
Dahl, S. G., & Strandjord, R. E. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977214437 · Cited by 105
Major morbidity or mortality from office anesthetic procedures: a closed-claim analysis of 13 cases.
Jastak, J. T., & Peskin, R. M. (1992) · PubMed · Cited by 103
Frequency, consequences and prevention of adverse drug events
Bates, D. W. (1999) · J Qual Clin Practice · doi:10.1046/j.1440-1762.1999.00285.x · Cited by 103
Litman, R. S., Kottra, J. A., Verga, K. A., Berkowitz, R. J., & Ward, D. S. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199804000-00009 · Cited by 101
The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine
Simons, F. E. R., Simons, K. J., & Frith, E. M. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90486-x · Cited by 100
Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation*
Tallgren, M. K., Olkkola, K. T., Seppαlä, T., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90100-4 · Cited by 96
Age-Related Morphine Kinetics in Infants
Pokela, M., Olkkola, K. T., Seppälä, T., & Koivisto, M. E. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457538 · Cited by 90
Litman, R. S. (1996) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1996.02170320017002 · Cited by 78
Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis
Lietman, P. S., Estelle, F., Simons, R., Simons, K. J., Becker, A. B., & Haydey, R. P. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80608-3 · Cited by 74
Litman, R. S., Kottra, J. A., Berkowitz, R. J., et al. (1997) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(97)90630-3 · Cited by 71
Errors in the intensive care unit (ICU)
Flaatten, H. K., & Hevrøy, O. (1999) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.1999.430604.x · Cited by 62
Prevention of Medication Errors in the Pediatric Inpatient Setting
(1998) · PEDIATRICS · doi:10.1542/peds.102.2.428 · Cited by 57
Triedman, J. K., & Saul, J. P. (1994) · The Journal of Clinical Monitoring · doi:10.1007/bf01651461 · Cited by 55
Paediatric Labelling Requirements
Wilson, J. T., KEARNS, G., Murphy, D., & Yaffe, S. J. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426040-00006 · Cited by 44
A pharmacokinetic interaction between roxithromycin and midazolam
Backman, J. T., Aranko, K., Himberg, J., & Olkkola, K. T. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00196114 · Cited by 38
Fentanyl, fads, and folly: Who will adopt the therapeutic orphans?
Kauffman, R. E. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82409-6 · Cited by 31
Peer Reviewer Agreement for Major Anesthetic Mishaps
Caplan, R. A., Posner, K. L., Ward, R. J., & Cheney, F. W. (1988) · QRB - Quality Review Bulletin · doi:10.1016/s0097-5990(16)30248-2 · Cited by 20
Are Medication Error Rates Useful as Comparative Measures of Organizational Performance?
van Leeuwen, D. H. (1994) · The Joint Commission Journal on Quality Improvement · doi:10.1016/s1070-3241(16)30061-x · Cited by 20
med W atch : FDA'S Medical Products Reporting Program
Goldman, S. A., & Kennedy, D. L. (1998) · Postgraduate Medicine · doi:10.3810/pgm.1998.03.408 · Cited by 13
Chlorpromazine excretion by the neonate following chronic in utero exposure.
Nielsen, H. C., Wiriyathian, S., Rosenfeld, R. G., et al. (1983) · PubMed · Cited by 11
Cited by
Coté, C. J., Wilson, S., AMERICAN ACADEMY OF PEDIATRICS, & AMERICAN ACADEMY OF PEDIATRIC DENTISTRY (2019) · Pediatrics · doi:10.1542/peds.2019-1000 · Cited by 1,406
Cravero, J. P., Beach, M. L., Blike, G. T., Gallagher, S. M., & Hertzog, J. H. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818fc334 · Cited by 607
Procedural sedation and analgesia in children
Krauss, B., & Green, S. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68230-5 · Cited by 564
American Academy of Pediatrics, American Academy of Pediatric Dentistry, Coté, C. J., Wilson, S., & the Work Group on Sedation (2006) · Pediatrics · doi:10.1542/peds.2006-2780 · Cited by 555
Self-citationCasamassimo, P. S., Thikkurissy, S., Edelstein, B. L., & Maiorini, E. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0250 · Cited by 510
Metadata
- Authors
- Coté, C. J., Karl, H. W., Notterman, D. A., Weinberg, J. A., & McCloskey, C.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2000-10-01
- Volume
- 106
- Issue
- 4
- Pages
- 633-644
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2107963414
- Cited by
- 616
- References
- 65
- FWCI
- 26.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.